Abstract.
A 12-year-old girl with short stature due to idiopathic Fanconi syndrome and chronic renal failure was treated with recombinant human growth hormone (rhGH). There was no family history of diabetes mellitus and the glucose tolerance before treatment was normal. Intravenous glucose tolerance tests were performed before, during and after treatment. Two months after starting rhGH the early phase of insulin secretion (1-+3-min values) was diminished, and the patient developed manifest diabetes mellitus with hyperglycemia and an elevated hemoglobin A1c. Following discontinuation of rhGH, glucose tolerance slowly returned to normal.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received May 29, 1997; received in revised form November 5, 1997; accepted November 12, 1997
Rights and permissions
About this article
Cite this article
Filler, G., Franke, D., Amendt, P. et al. Reversible diabetes mellitus during growth hormone therapy in chronic renal failure. Pediatr Nephrol 12, 405–407 (1998). https://doi.org/10.1007/s004670050475
Issue Date:
DOI: https://doi.org/10.1007/s004670050475